Summary
P2D Bioscience
Founded in 2005
Description
P2D Bioscience (P2D) is a specialty pharmaceutical company focused on developing innovative drugs that fulfill unmet medical needs in the treatment of central nervous system (CNS) and pulmonary disorders including attention deficit/hyperactivity disorder (ADHD), obesity, anxiety, depression, Alzheimers disease, traumatic brain injury and chronic obstructive pulmonary disease (COPD).\r\n \r\nAt P2D, our experienced drug development team utilizes our in-depth understanding of the clinical treatment of CNS disorders and neurodegenerative diseases to efficiently build a product portfolio of therapeutics with an improved likelihood for clinical success. Our goal is to advance a product candidate through preclinical development and clinical proof-of-concept by producing powerful and compelling clinical data and then seeking partners to complete the clinical development and commercialization process.\r\n \r\nP2D currently has a pipeline of nine drug candidates to treat ADHD, obesity and diabetes, Alzheimers disease, traumatic brain injury and COPD.
Strengths
- P2D Bioscience has a strong market share in their industry
- Revenue generated per employee is greater than industry average
- Since P2D Bioscience was founded, the company has grown faster than the industry average
Annual Revenue
P2D Bioscience's annual revenue
$1812000
Based on Kona Equity data
-
Revenue per employee
$453000
-
Annual revenue growth since founding
$95368
Employee Count
4 employees
Executives
Frank Zemlan
Chief Executive Officer
f**@p2dinc.comRenee Connor
Senior Research Coordinator
r**@p2dinc.comPrasad Gabbita
Chief Executive Officer
p**@p2dinc.comPhone Manufacturing
Chief Executive Officer
p**@p2dinc.comG Score - 3
The G Score is an eight-point scale where firms are given a score of 1 for each of the criteria that they pass. The G score compares a company against the industry median to find those that are healthy and growing.
- G1 Revenue is greater than the industry median.
- G2 Income per employee more than industry average.
- G6 Annual revenue growth since founding is higher than the industry average.
Location
Unlock unlimited leads
Similar Companies
Key Information
- Name: P2D Bioscience
- Category: Pharmaceuticals
- Industry: Pharmaceutical company
- SIC: 28; 283
- NAICS: 32; 325
See similar companies
-
By City Cincinnati Small Pharmaceutical company in Cincinnati Mid-size Pharmaceutical company in Cincinnati Pharmaceuticals in Cincinnati Small Pharmaceuticals in Cincinnati Mid-size Pharmaceuticals in Cincinnati
-
By State OH Small companies in OH Pharmaceuticals in OH Small Pharmaceuticals in OH Mid-size Pharmaceuticals in OH Small Pharmaceutical company in OH Mid-size Pharmaceutical company in OH
-
By Category Pharmaceuticals Small Pharmaceuticals Mid-size Pharmaceuticals
-
By Industry Pharmaceutical company Small Pharmaceutical company Mid-size Pharmaceutical company Pharmaceuticals and Pharmaceutical company
-
Firmographic data G Score of 3 Founded in 2005 SIC: 28 SIC: 283 NAICS: 32 NAICS: 325 #Manufacturing #Pharmaceuticals
Frequently Asked Questions
P2D Bioscience's official website is p2dinc.com
P2D Bioscience's annual revenue is $1.8 M.
P2D Bioscience's SIC: 28; 283
P2D Bioscience's NAICS: 32; 325.
P2D Bioscience has 4 employees
P2D Bioscience is in the industry of Pharmaceuticals.